Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm -Q1 parent results

Aug 3 (Reuters)-  
             Wakamoto Pharmaceutical Co Ltd  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             2.89                2.82             11.20     
                 (+2.4 pct)          (+7.8 pct)       (+0.1 pct)   
  Operating        125 mln             126 mln          60 mln     
                 (-1.0 pct)         (+684.7 pct)      (-27.9 pct)  
  Recurring        130 mln             144 mln          40 mln     
                 (-9.6 pct)                           (-68.0 pct)  
  Net              85 mln              90 mln            2 mln     
                 (-5.2 pct)         (+164.9 pct)      (-90.2 pct)  
  EPS             2.46 yen            2.59 yen         0.06 yen    
  Ann Div                             3.00 yen                     
  -Q2 div                                NIL                       
  -Q4 div                             3.00 yen                     
   
  NOTE - Wakamoto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Wakamoto Pharmaceutical

See all news